Needham & Company LLC reiterated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $60.00 price objective on the stock. A number of other analysts have also commented on APLS. Oppenheimer reissued an outperform rating on shares […]
Apellis Pharmaceuticals (NASDAQ:APLS) PT Raised to $64 00 at UBS Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $82.00 price target on the stock. APLS has been the topic of several other research reports. Wells Fargo & Company decreased their target price on […]
Oppenheimer reissued their outperform rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. APLS has been the subject of a number of other research reports. Robert W. Baird lowered their price target on Apellis Pharmaceuticals from $115.00 to $70.00 and set an outperform […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They currently have a $60.00 price target on the stock. Needham & Company LLC’s target price suggests a potential upside of 47.17% from the […]